These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates. Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557 [TBL] [Abstract][Full Text] [Related]
23. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Ruiz J; Núñez ML; Pérez J; Simarro E; Martínez-Campos L; Gómez J Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):292-5. PubMed ID: 10385020 [TBL] [Abstract][Full Text] [Related]
24. In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood. Chang SC; Chen YC; Luh KT; Hsieh WC Diagn Microbiol Infect Dis; 1995 Nov; 23(3):105-110. PubMed ID: 8849654 [TBL] [Abstract][Full Text] [Related]
25. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates. Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043 [TBL] [Abstract][Full Text] [Related]
26. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002]. Akan OA Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260 [TBL] [Abstract][Full Text] [Related]
27. In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates. Owens RC; Banevicius MA; Nicolau DP; Nightingale CH; Quintiliani R Antimicrob Agents Chemother; 1997 Nov; 41(11):2586-8. PubMed ID: 9371376 [TBL] [Abstract][Full Text] [Related]
28. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong. Ling TK; Ying CM; Lee CC; Liu ZK Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700 [TBL] [Abstract][Full Text] [Related]
29. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat. Carvalheira A; Casquete R; Silva J; Teixeira P Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Bonapace CR; White RL; Friedrich LV; Bosso JA Diagn Microbiol Infect Dis; 2000 Sep; 38(1):43-50. PubMed ID: 11025183 [TBL] [Abstract][Full Text] [Related]
31. Rodriguez CH; Brune A; Nastro M; Vay C; Famiglietti A J Med Microbiol; 2020 Jul; 69(7):928-931. PubMed ID: 32584214 [No Abstract] [Full Text] [Related]
32. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii. Shi ZY; Liu PY; Lau Y; Lin Y; Hu BS; Shir J-M Diagn Microbiol Infect Dis; 1996 Feb; 24(2):81-5. PubMed ID: 9147913 [TBL] [Abstract][Full Text] [Related]
33. Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Giamarellos-Bourboulis EJ; Xirouchaki E; Giamarellou H Diagn Microbiol Infect Dis; 2001 Jul; 40(3):117-20. PubMed ID: 11502379 [TBL] [Abstract][Full Text] [Related]
34. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii. Temocin F; Erdinc FS; Tulek N; Demirelli M; Ertem G; Kinikli S; Koksal E Braz J Microbiol; 2015; 46(4):1119-24. PubMed ID: 26691470 [TBL] [Abstract][Full Text] [Related]
36. Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. Joly-Guillou ML; Decré D; Herrman JL; Bourdelier E; Bergogne-Bérézin E J Antimicrob Chemother; 1995 Oct; 36(4):619-29. PubMed ID: 8591936 [TBL] [Abstract][Full Text] [Related]
37. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [TBL] [Abstract][Full Text] [Related]
38. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948 [TBL] [Abstract][Full Text] [Related]
39. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital. Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437 [TBL] [Abstract][Full Text] [Related]
40. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii. Wang Y; Li X; Wang D; Sun S; Lu C Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]